Pilot study evaluating the role of cardiac magnetic resonance imaging in monitoring adjuvant trastuzumab therapy for breast cancer
- 12 January 2012
- journal article
- Published by Wiley in Asia-Pacific Journal of Clinical Oncology
- Vol. 8 (1) , 95-100
Abstract
Aim: To explore the incidence of subclinical cardiotoxicity in women treated with adjuvant trastuzumab in the early breast cancer setting using cardiac magnetic resonance imaging (cMRI).Methods: The cardiac function and myocardial tissue characteristics of 25 women who had completed adjuvant trastuzumab therapy greater than 6 months previously was evaluated using MRI and comparing this with symptoms and routine echocardiography.Results: Evidence of myocardial tissue damage was seen in two women in the absence of functional change or previous cardiac symptoms.Conclusion: Tissue characterization using cMRI may provide a useful tool in defining trastuzumab induced cardiotoxicity.Keywords
This publication has 32 references indexed in Scilit:
- The Prognostic Implications of Cardiovascular Magnetic ResonanceCirculation: Cardiovascular Imaging, 2009
- Myocardial Late Gadolinium Enhancement: Prevalence, Pattern, and Prognostic Relevance in Marathon RunnersRadiology, 2009
- Minimizing Cardiotoxicity While Optimizing Treatment Efficacy with Trastuzumab: Review and Expert RecommendationsThe Oncologist, 2009
- Incidence and Prognostic Implication of Unrecognized Myocardial Scar Characterized by Cardiac Magnetic Resonance in Diabetic Patients Without Clinical Evidence of Myocardial InfarctionCirculation, 2008
- Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathyAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Comparison of the reproducibility of quantitative cardiac left ventricular assessments in healthy volunteers using different MRI scanners: A multicenter simulationJournal of Magnetic Resonance Imaging, 2008
- Late Gadolinium Enhancement by Cardiovascular Magnetic Resonance Heralds an Adverse Prognosis in Nonischemic CardiomyopathyJACC, 2008
- Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathyJournal of Cardiovascular Magnetic Resonance, 2008
- Cardiac pathology of fatal trastuzumab therapy: Figure 1Journal of Clinical Pathology, 2007
- Mid-Myocardial Fibrosis by Cardiac Magnetic Resonance in Patients with Lamin A/C Cardiomyopathy: Possible Substrate for Diastolic DysfunctionJournal of Cardiovascular Magnetic Resonance, 2007